Skip to main content
Equibles
CRDF logo

CRDF · Cardiff Oncology, Inc. · Share Buybacks

Track CRDF — free

Use CRDF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRDF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.91 +0.01 (+1.59%) Q4 2024 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$69.83M
Shares
77.80M
Volume · Oct 29 123.21K Avg daily vol (3M) 679.76K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

No Buyback Data

This company's XBRL filings report no share-repurchase activity yet.

Key facts CIK 1213037 CUSIP 14147L108 13F (30d) 15 filings 15 filers Visit website Investor relations